Severity
Moderate
FDA Devices recall · Reported December 26, 2018
lack of 510K
Clark Laboratories, Inc. (dba,Trinity Biotech USA) recalled Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liq… - a moderate-severity action.
Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liq… was recalled by Clark Laboratories, Inc. (dba,Trinity Biotech USA) in December 26, 2018. Reason: lack of 510K. Check the official notice for the remedy. Verify recall #Z-0622-2019 with the FDA Devices before acting.
The recall
Clark Laboratories, Inc. (dba,Trinity Biotech USA) issued this moderate-severity FDA Devices recall-lack of 510K.
Sourced from official FDA Devices enforcement records. Verify recall #Z-0622-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0622-2019) was formally reported on December 26, 2018, with the manufacturer initiating the action on November 1, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. Clark Laboratories, Inc. (dba,Trinity Biotech USA) is listed as the recalling firm, operating out of Jamestown, NY. Federal records list the affected scope as 252 units.
The documented reason for this recall is: lack of 510K Distribution data in the federal record shows the product reached: IL, WV, NJ, AZ, MD, UT. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,422 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
252 units
Related Recalls
6
0 from same agency
Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
lack of 510K
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-0622-2019 |
| Date reported | December 26, 2018 |
| Date initiated | November 1, 2018 |
| Recalling firm | Clark Laboratories, Inc. (dba,Trinity Biotech USA) |
| Firm location | Jamestown, NY |
| Affected scope | 252 units |
| Distribution | IL, WV, NJ, AZ, MD, UT |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-07-02
· 2026-07-02
· 2026-06-25
· 2026-06-25
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported December 26, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.